Press Office

Inserm in the news

Founded in 1964, the French National Institute of Health and Medical research (Inserm) is a public science and technology institute, jointly supervised by the French Ministry of National Education, Higher Education and Research and the Ministry of Social Affairs, Health and women’s Rights. Inserm is the only French public research institute to focus entirely on human health and positions itself on the pathway from research laboratory to the bed of the patient. The mission of its scientists is to study all diseases, from the most common to the rarest. With an initial 2020 budget of €927.28 million, Inserm supports nearly 350 laboratories throughout France. All the teams include nearly 14,000 researchers, engineers, technicians, managers, university hospitals, post-doctoral fellows, etc. See infographic showing Inserm in numbers Inserm-medias-icons

Excluding social media, there were 23,500 spinoffs mentioning Inserm in 2018, more than doubling the volume compared to the same period in 2017. This increase is driven by online press sites and audiovisual media, particularly radio, where the number of topics (1500) devoted to Inserm has tripled.

Print media coverage remains stable with a top 3 represented by Le Figaro, Le Monde and AFP; media in which Inserm is mentioned every 4 days on average.

In TV and radio, it is mainly the national channels that are at the origin of Inserm’s increased exposure. In radio, these increases are concentrated in particular on France Culture, RFI and France Inter (thanks, in particular, to the programmes La Tête au Carré, la Méthode scientifique and Priorité Santé). In TV: strong growth in exposure on France 5; France 2, M6 and continuous news channels.

Among the most important scientific news in 2018, advances in public health were, as always, widely reported by the media, particularly in the field of food and its risks to health, work carried out by Serge Hercberg’s team. A CESP team is also at the origin of the new growth curves that appear in the latest edition of the health booklet.

On the international media scene, Inserm and IRD were the first, as early as May, to characterize the nature of the Ebola virus that caused the 9th epidemic currently raging in the DRC.

On the clinical research side, the results of a trial conducted on 19 patients suffering from Hyper Growth Syndromes and emblematic of the continuity between fundamental and clinical research, were widely reported in the press.

In April, the partnership signed between Inserm and startup Owkin marked a year dedicated to AI.

Finally, to make the link between 2018 and 2019, the 5300 expedition, a scientific mission to the world’s highest city in February 2019, was announced in November. Major national (Le Monde) and international (Science) media will follow the expedition on site.

From a communication point of view, Inserm launched “Canal Détox” in September, a scientific information tool for all aimed at combating preconceived ideas. The series’ humorous teaser was a great success with more than 200,000 views and triggered numerous press articles and partnerships. In January, all the episodes were seen more than 500,000 times on our various social networks.

In order to share the richness of the images produced by scientists, an intstagram account was launched at the end of the year.

3 FacebookLive, lasting 30 to 40 minutes, were created in 2018 (in May on World Asthma Day, in September on the occasion of the conference: Screens: What upheavals for the brain and in December on the occasion of AIDS Day.

On social media, Inserm had 110,000 subscribers on Twitter 25,000 on Facebook 51,000 subscribers to the Youtube channel 36,000 subscribers on LinkedIn as of 1 January 2019



See also
Media partners

The Conversation Inserm is a partner of The Conversation.fr, an independent, non-profit media based on content from the university community Le Figaro Several times a year, Inserm researchers answer questions from readers of the daily Le Figaro in the health supplement published on Mondays. If you wish to develop a collaboration with the Inserm press service: contact us!

fermer
fermer
RSS Youtube